EUVIMEDEUVIMED entdecken
Crossref

Optimal Immunization Strategy for Protection of Children < 1 Year Against Respiratory Syncytial Virus Infection and Hospitalization

Juan-Carlos Cortés, Mónica López-Lacort, Ainara Mira-Iglesias, Cristina-Luisovna Pérez, Rafael-Jacinto Villanueva, Javier Villanueva-Oller

Bulletin of Mathematical Biology · 2026

DOI: 10.1007/s11538-025-01575-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of Mathematical Biology, 2026. Verfasst von Juan-Carlos Cortés und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Universitario de Matemática Multidisciplinar, Universitat Politècnica de València, Valencia, Spain. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Hospitalization, Respiratory Syncytial Virus Vaccines. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Merck Sharp & Dohme Spain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory Syncytial Virus (RSV) can lead to severe bronchiolitis and pneumonia, especially in children under one year of age. The introduction of vaccines and immunoprophylaxis has highlighted the need for more representative models to evaluate their impact on public health strategies. In Spain, Nirsevimab, a recombinant human monoclonal antibody against RSV, was added to the 2023 immunization schedule for children, administered as a single intramuscular dose. We developed an agent-based model representing the population of the Valencian Community (CVA), Spain, to simulate RSV transmission and assess various immunization strategies. This model integrates demographic factors and incorporates random transitions between states. It also takes into account that the effectiveness of existing immunoprophylaxis decreases over time. Using this model, we systematically evaluated 133 contiguous-month immunization strategies and the non-immunization scenario. To determine the effectiveness of these strategies, we compared simulated outcomes related to hospitalizations in children aged 0-5 months and those under one year, as well as the incidence of infections in these age groups. Our findings show that several immunization strategies effectively reduce hospitalizations and infections in infants aged 0-5 months to a similar extent. Targeting newborns between October and March/April, along with immunizing children under one year of age born outside this period in October, consistently ranks among the best-performing approaches across multiple evaluation criteria. These strategies offer a strong balance between health impact and immunization effort, and are particularly effective in reducing hospitalizations among infants under one year.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsHospitalizationRespiratory Syncytial Virus VaccinesHumansInfantInfant, NewbornSpainImmunization ScheduleMathematical ConceptsComputer SimulationAntibodies, Monoclonal, HumanizedRespiratory Syncytial Virus, Human

Stichwörter der Autor:innen

Agent-based modelImmunizationMathematical modelingOptimal strategyProbabilistic calibrationRespiratory Syncytial Virus

Substanzen

Respiratory Syncytial Virus VaccinesAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Instituto Universitario de Matemática Multidisciplinar, Universitat Politècnica de València, Valencia, Spain.
  • Vaccines Research Unit, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO-Public Health, Valencia, Spain.
  • CIBER of Epidemiology and Public Health, Instituto de Salud Carlos III, Madrid, Spain.
  • Instituto Universitario de Matemática Multidisciplinar, Universitat Politècnica de València, Valencia, Spain. cperdiu@upv.es.
  • Departamento de Informática y Estadística, Universidad Rey Juan Carlos, Móstoles, Madrid, Spain.

Förderung

  • Merck Sharp & Dohme Spain

Zitieren

APA

Cortés, J. C., López-Lacort, M., Mira-Iglesias, A., Pérez, C. L., Villanueva, R. J., & Villanueva-Oller, J. (2026). Optimal Immunization Strategy for Protection of Children < 1 Year Against Respiratory Syncytial Virus Infection and Hospitalization. Bulletin of Mathematical Biology. https://doi.org/10.1007/s11538-025-01575-2

Vancouver

Cortés JC, López-Lacort M, Mira-Iglesias A, Pérez CL, Villanueva RJ, Villanueva-Oller J. Optimal Immunization Strategy for Protection of Children < 1 Year Against Respiratory Syncytial Virus Infection and Hospitalization. Bulletin of Mathematical Biology. 2026. doi:10.1007/s11538-025-01575-2

BibTeX
@article{Corts2026,
  author = {Cortés, Juan-Carlos and López-Lacort, Mónica and Mira-Iglesias, Ainara and Pérez, Cristina-Luisovna and Villanueva, Rafael-Jacinto and Villanueva-Oller, Javier},
  title = {Optimal Immunization Strategy for Protection of Children < 1 Year Against Respiratory Syncytial Virus Infection and Hospitalization},
  journal = {Bulletin of Mathematical Biology},
  year = {2026},
  doi = {10.1007/s11538-025-01575-2}
}
Kostenlos starten →